Medtronic Plc
MDTLast close · Oct 16, 202694.75−0.70 (−0.73%)
Market cap$121.2B
Between Jun 8, 2026 and Oct 15, 2026, Medtronic (MDT) insiders filed 40 Form 4 transactions: 5 sales worth $6.5M in total and no open-market purchase; 3 of the sales were under 10b5-1 plans set in advance. The largest seller was Martha Geoffrey, $4.8M. 35 other filings were grants, exercises or gifts, which say nothing about buying or selling.
40
0
5
3
Form 4 transactions
| Date | Insider | Title | Code | Plan | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Marinaro Michael | EVP, Pres MedSurg and Americas | S | 10b5-1 | 10,420 | 96.00 | $1.0M |
| 2026-10-15 | Martha Geoffrey | Chairman and CEO | S | 10b5-1 | 50,000 | 95.00 | $4.8M |
| 2026-09-16 | KIIL HARRY SKIP | EVP & President Cardiovascular | S | 1,483 | 93.65 | $138,883 | |
| 2026-09-15 | Blomquist Denise L. | Chief Accounting Officer | G | 600 | 0.00 | $0 | |
| 2026-08-20 | Marinaro Michael | EVP, Pres MedSurg and Americas | F | 1,084 | 92.30 | $100,053.2 | |
| 2026-07-31 | Blomquist Denise L. | Chief Accounting Officer | F | 212 | 85.39 | $18,102.7 | |
| 2026-08-03 | Blomquist Denise L. | Chief Accounting Officer | A | 2,337 | 0.00 | $0 | |
| 2026-08-03 | Blomquist Denise L. | Chief Accounting Officer | A | 2,337 | 0.00 | $0 | |
| 2026-08-03 | Blomquist Denise L. | Chief Accounting Officer | A | 1,366 | 0.00 | $0 | |
| 2026-07-31 | Walter Matthew R. | SVP, Chief HR Officer | F | 1,675 | 85.39 | $143,028.3 | |
| 2026-08-03 | Walter Matthew R. | SVP, Chief HR Officer | A | 5,769 | 0.00 | $0 | |
| 2026-08-03 | Walter Matthew R. | SVP, Chief HR Officer | A | 14,421 | 0.00 | $0 | |
| 2026-08-03 | Walter Matthew R. | SVP, Chief HR Officer | A | 40,973 | 0.00 | $0 | |
| 2026-07-31 | Thompson Kweli | EVP & President, Neuroscience | F | 1,739 | 85.39 | $148,493.2 | |
| 2026-08-03 | Thompson Kweli | EVP & President, Neuroscience | A | 6,923 | 0.00 | $0 | |
| 2026-08-03 | Thompson Kweli | EVP & President, Neuroscience | A | 17,306 | 0.00 | $0 | |
| 2026-08-03 | Thompson Kweli | EVP & President, Neuroscience | A | 49,167 | 0.00 | $0 | |
| 2026-08-03 | Quinn Michelle | EVP, GC and Secretary | A | 15,863 | 0.00 | $0 | |
| 2026-08-03 | Quinn Michelle | EVP, GC and Secretary | A | 6,346 | 0.00 | $0 | |
| 2026-08-03 | Quinn Michelle | EVP, GC and Secretary | A | 45,070 | 0.00 | $0 | |
| 2026-08-03 | Pieton Thierry | EVP & Chief Financial Officer | A | 11,537 | 0.00 | $0 | |
| 2026-08-03 | Pieton Thierry | EVP & Chief Financial Officer | A | 28,842 | 0.00 | $0 | |
| 2026-08-03 | Pieton Thierry | EVP & Chief Financial Officer | A | 81,945 | 0.00 | $0 | |
| 2026-07-31 | Marinaro Michael | EVP, Pres MedSurg and Americas | F | 3,356 | 85.39 | $286,568.8 | |
| 2026-08-03 | Marinaro Michael | EVP, Pres MedSurg and Americas | A | 10,960 | 0.00 | $0 | |
| 2026-08-03 | Marinaro Michael | EVP, Pres MedSurg and Americas | A | 46,147 | 0.00 | $0 | |
| 2026-08-03 | Marinaro Michael | EVP, Pres MedSurg and Americas | A | 27,400 | 0.00 | $0 | |
| 2026-08-03 | Marinaro Michael | EVP, Pres MedSurg and Americas | A | 77,848 | 0.00 | $0 | |
| 2026-07-31 | KIIL HARRY SKIP | EVP & President Cardiovascular | F | 3,074 | 85.39 | $262,488.9 | |
| 2026-08-03 | KIIL HARRY SKIP | EVP & President Cardiovascular | A | 9,230 | 0.00 | $0 | |
| 2026-08-03 | KIIL HARRY SKIP | EVP & President Cardiovascular | A | 23,074 | 0.00 | $0 | |
| 2026-08-03 | KIIL HARRY SKIP | EVP & President Cardiovascular | A | 65,556 | 0.00 | $0 | |
| 2026-07-31 | Martha Geoffrey | Chairman and CEO | F | 15,810 | 85.39 | $1.4M | |
| 2026-08-03 | Martha Geoffrey | Chairman and CEO | A | 41,533 | 0.00 | $0 | |
| 2026-08-03 | Martha Geoffrey | Chairman and CEO | A | 103,831 | 0.00 | $0 | |
| 2026-08-03 | Martha Geoffrey | Chairman and CEO | A | 295,002 | 0.00 | $0 | |
| 2026-08-03 | Martha Geoffrey | Chairman and CEO | A | 273,150 | 0.00 | $0 | |
| 2026-07-28 | Quinn Michelle | EVP, GC and Secretary | F | 2,069 | 86.88 | $179,754.7 | |
| 2026-07-08 | Walter Matthew R. | SVP, Chief HR Officer | S | 10b5-1 | 3,102 | 83.15 | $257,931.3 |
| 2026-06-08 | KIIL HARRY SKIP | EVP & President Cardiovascular | S | 3,961 | 80.44 | $318,622.8 |
Codes are the SEC's: P open-market purchase, S open-market sale; M exercise, F tax withholding, A grant and G gift are routine. A 10b5-1 flag means the trade ran under a plan adopted in advance. Method notes in where the numbers come from.